<DOC>
	<DOC>NCT01224626</DOC>
	<brief_summary>To collect the efficacy and safety information in subjects who have been treated with Zyvox (linezolid) for vancomycin resistance Enterococcus faecium infection for their appropriate use in daily practice.</brief_summary>
	<brief_title>Zyvox (Linezolid) Special Investigation For Vancomycin-Resistant Enterococci (VRE)</brief_title>
	<detailed_description />
	<mesh_term>Linezolid</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<criteria>Subject to whom Zyvox (linezolid) was administered. Infected subject with Vancomycin resistance Enterococcus faecium. Infected subject with MRSA and other organism.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>VRE</keyword>
	<keyword>Japanese</keyword>
	<keyword>Post Marketing Surveillance</keyword>
</DOC>